A carregar...
Clinical use of the β(3) adrenoceptor agonist mirabegron in patients with overactive bladder syndrome
Mirabegron is a β(3) adrenoceptor agonist licensed for the treatment of overactive bladder symptoms, such as urinary urgency or urgency incontinence. β(3) adrenoceptor activation causes detrusor muscle relaxation, but mirabegron may also act by binding other targets in the bladder, and it may also r...
Na minha lista:
| Publicado no: | Ther Adv Urol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4549701/ https://ncbi.nlm.nih.gov/pubmed/26425139 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756287215591763 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|